Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

BUY

The chart is a work of art. It just goes up. To calculate a stop loss, draw a straight line just below the bottom of the trend. As long as it stays above that line, don't worry about it.

BUY

Great company. Expecting 12% earnings growth. Good core holding for anyone's portfolio.

BUY

Sees more growth in the life companies than in the banks. Likes their Asian operations.

BUY

Had a big run late last year. Well managed. Good exposure in Asia.

BUY

Likes the long-term nature of the insurance companies with their wealth management.

BUY

Superbly run and gives good exposure to the US and the Far East.

BUY

Great company. Very well managed. Good track record. Very well exposed in Asia.

TOP PICK

(A Top Pick July 4/06. Up 11%.) Has actually been laggard in the group. John Hancock acquisition has been very successful. Still happy with it. ROE of over 16% and a PE of about 15.

BUY

A world-class Canadian company. One of the top 10 life-insurance companies in Japan. Making money in China.

BUY ON WEAKNESS

Likes it under $39. Well-run. Lots of growth in Asia. Decent US exposure.

BUY

His favourite insurance company in Canada. Best management. Great growth opportunities in the Far East. Have built up a lot of cash and have the ability to make a major acquisition.

BUY

Market was disappointed in their sales. He likes their prospects in Asia. Good long-term hold.

BUY

Would buy at this price.

HOLD

Tremendously well managed. While diversified by geography and business line. Had a huge run and he questions if he should start trimming. Would look to buy on any weakness.

PAST TOP PICK

(A Top Pick Oct 2/06. Up 12.2%.) Still owns, but has scaled back because she thinks it is going to hit a wall for a while.

Showing 1,816 to 1,830 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)